PVP Ventures Limited has informed the Exchange regarding a press release dated August 28, 2025, titled "Press Release".
PVP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
PVP Ventures has signed binding agreements to acquire an initial 41.23% stake in 7 Med India and Epitome Hospitals, with a contracted path to majority ownership within 12 months and eventually increasing its stake to 76%. The total outlay for the majority shareholding is approximately INR 127 crores, through a mix of primary and secondary share purchases, with further investments tied to financial milestones. 7 Med operates 22 dialysis and super-speciality hospitals across 6 states with 450+ professionals and is already profitable with an EBITDA of about INR 10 crores. PVP expects 7 Med's EBITDA to grow to INR 50 crores over the next 4 years, with plans to expand into Tier 2 and Tier 3 cities. This is part of PVP's broader strategy to build a healthcare services platform, funded by expected cash flows of over INR 2,000 crores from its real estate development agreements with Brigade and Casagrand.
This is a significant strategic pivot for PVP Ventures into the healthcare sector and could be viewed positively by investors as it diversifies revenue beyond the legacy real estate business. The acquisition of a profitable, top-5 player in India's organized renal care space at a clear valuation offers visible growth, though execution risk and the staged ownership structure mean the full benefit will unfold over several years.